Component composition of the body in children with chronic kidney disease according to the results of bioimpedansometry

Body composition reflects the dynamic processes in a child’s development. The recommended restrictive diets for patients with advanced chronic kidney disease (CKD) contribute to a high risk of sarcopenic muscle wasting as diagnosed by bioimpedancemetry.

The aim of the study. To assess BMI and body composition in children with CKD, to identify features of body composition in patients with different BMI Z-score values.

Materials and methods. The physical development of 110 children with CKD of different stages was assessed. Patients were divided into two clusters: Group 1 (92 children) with BMI from 10.95 to 21.5 kg/m², BMI Z-score did not exceed +2.0 (without obesity); Group 2 (18 children) – BMI from 24.11 to 37.2 kg/m², Z-score BMI – more than +2.0 (obese). All underwent bioimpedancemetry, the proportion of fat and active cell mass was assessed. The comparison was carried out by nonparametric statistics methods.

Results. Changes in body composition were revealed: children without obesity had severe protein-energy deficiency in 7 cases (7.6 %). The difference in the proportion of fat mass in children of different groups, Me [Q1; Q3]: Group 1 – 18.00 % [14.00; 22.00], Group 2 – 35.00 % [21.98; 41.00], (Mann – Whitney U-test: U = 279.5, p = 0.00001). In Group 1, the active cell mass was 53.50 % [51.00; 56.00], in Group 2 – 41.50 % [39.00; 47.00] (U = 174.5, p = 0.000001), there were no significant differences in other parameters of bioimpedancemetry.

Conclusions. The proportion of active cell mass is lower in overweight children, with a significant predominance of the proportion of fat mass, which indicates the depletion of protein reserves due to their redistribution and possible insufficient alimentary intake in advanced stages of CKD.

1. Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013; 158(11): 825-830. doi: 10.7326/0003-4819-158-11-201306040-00007

2. Chronic kidney disease. Clinical guidelines. Age group – children (draft). 2022. URL: https://cr.minzdrav.gov.ru/recomend/713_1 [date of access: 20.12.2022]. (In Russ.).

3. Kanda E, Kashihara N, Matsushita K, Usui T, Okada H, Iseki K, et al. Guidelines for clinical evaluation of chronic kidney disease: AMED research on regulatory science of pharmaceuticals and medical devices. Clin Exp Nephrol. 2018; 22(6): 1446-1475. doi: 10.1007/s10157-018-1615-x

4. Gurina OP, Dement’eva EA, Blinov AE, Varlamova ON, Stepanova AA, Blinov GA. Immunophenotype of lymphocytes in virus-associated glomerulonephritis in children. Sovremennaya pediatriya. Sankt-Peterburg – Belye Nochi – 2018: Materialy konferentsii. Saint Petersburg; 2018: 38-39. (In Russ.).

5. Gurova MM, Romanova TA, Sysoeva NYa, Rubtsova LV, Grevtseva OM, Ivashchenko EV, et al. A case of polycystic disease in the differential diagnosis of diseases occurring with hepatomegaly. Aktual’nye voprosy kompleksnoy reabilitatsii detey: ot teorii k praktike: Sbornik trudov Mezhregional’noy nauchno-prakticheskoy konferentsii, posvyashchennoy 110-letnemu yubileyu GBUZ «Detskiy sanatoriy – Reabilitatsionnyy tsentr «Detskie Dyuny». Saint Peterburg: InformMed Publ.; 2016: 279-284. (In Russ.).

6. Smirnova MM, Savenkova ND, Tyrtova LV, Gurina OP. Thyroid status in children with steroidsensitive nephrotic syndrome. Nephrology (Saint-Petersburg). 2011; 15(3): 51-55. (In Russ.). doi: 10.24884/1561-6274-2011-15-3-51-55

7. Smirnova MM, Savenkova ND, Tyrtova LV, Gurina OP. The frequency of autoimmune thyroiditis in children with various types of glomerulonephritis. Pediatrician (St. Petersburg). 2012; 3(3): 37-41. (In Russ.).

8. Ahmetshin RZ, Lutfarakhmanov II., Mironov PI. Risk factors of progression of chronic kidney disease in children with congenital malformations of the urinary tract in the postoperative period. Pediatrician (St. Petersburg). 2017; 8(3): 69-74. (In Russ.). doi: 10.17816/PED8369-74

9. Prometnaya GA, Batushin MM, Bondarenko NB. Importance of activity of autophagy, apoptosis and intracellular protein degradation for early detection of malnutrition in patients with chronic kidney disease of 5th stage, receiving of hemodialysis: the results of case-control study. Pediatrician (St. Petersburg). 2018; 9(6): 29-36. (In Russ.). doi: 10.17816/PED9629-36

10. Sorvacheva TN, Evdokimova TA, Pyrieva EA, Volkova LYu. Malnutrition in young children. Principles of nutritional support. Russian Pediatric Journal. 2015; 18(2): 47-53. (In Russ.).

11. Mastrangelo A, Paglialonga F, Edefonti A. Assessment of nutritional status in children with chronic kidney disease and on dialysis. Pediatr Nephrol. 2014; 29(8): 1349-1358. doi: 10.1007/s00467-013-2612-7

12. Firsova LA, Gurova MM, Zavyalova AN. Chronic kidney disease and comorbid diseases of gastrointestinal tract. Experimental and Clinical Gastroenterology. 2022; 197(1): 110-119. (In Russ.). doi: 10.31146/1682-8658-ecg-197-1-110-119

13. Jiang K, Singh Maharjan SR, Slee A, Davenport A. Differences between anthropometric and bioimpedance measurements of muscle mass in the arm and hand grip and pinch strength in patients with chronic kidney disease. Clin Nutr. 2021; 40(1): 320-323. doi: 10.1016/j.clnu.2020.04.026

14. Tieland M, Trouwborst I, Clark BC. Skeletal muscle performance and ageing. J Cachexia Sarcopenia Muscle. 2018; 9(1): 3-19. doi: 10.1002/jcsm.12238

15. An JN, Kim JK, Lee HS, Kim SG, Kim HJ, Song YR. Late stage 3 chronic kidney disease is an independent risk factor for sarcopenia, but not proteinuria. Sci Rep. 2021; 11(1): 18472. doi: 10.1038/s41598-021-97952-7

16. Hara H, Nakamura Y, Hatano M, Iwashita T, Shimizu T, Ogawa T, et al. Protein energy wasting and sarcopenia in dialysis patients. Contrib Nephrol. 2018; 196: 243-249. doi: 10.1159/000485729

17. Shu X, Lin T, Wang H, Zhao Y, Jiang T, Peng X, et al. Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: A systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022; 13(1): 145-158. doi: 10.1002/jcsm.12890

18. Yoowannakul S, Tangvoraphonkchai K, Davenport A. The prevalence of muscle wasting (sarcopenia) in peritoneal dialysis patients varies with ethnicity due to differences in muscle mass measured by bioimpedance. Eur J Clin Nutr. 2018; 72(3): 381-387. doi: 10.1038/s41430-017-0033-6

19. Abro A, Delicata LA, Vongsanim S, Davenport A. Differences in the prevalence of sarcopenia in peritoneal dialysis patients using hand grip strength and appendicular lean mass: Depends upon guideline definitions. Eur J Clin Nutr. 2018; 72(7): 993-999. doi: 10.1038/s41430-018-0238-3

20. Sabatino A, Cuppari L, Stenvinkel P, Lindholm B, Avesani CM. Sarcopenia in chronic kidney disease: What have we learned so far? J Nephrol. 2021; 34(4): 1347-1372. doi: 10.1007/s40620-020-00840-y

21. Mangus RS, Bush WJ, Miller C, Kubal CA. Severe sarcopenia and increased fat stores in pediatric patients with liver, kidney, or intestine failure. J Pediatr Gastroenterol Nutr. 2017; 65(5): 579583. doi: 10.1097/MPG.0000000000001651

22. Dedov II, Mokrysheva NG, Mel’nichenko GA, Troshina EA, Mazurina NV, Ershova EV, et al. Obesity. Clinical guidelines. Consilium Medicum. 2021; 23(4): 311-325. (In Russ.). doi: 10.26442/20751753.2021.4.200832

23. Švigelj M, Golob Jančič S, Močnik M, Marčun Varda N. Body composition obtained by bioelectrical impedance with a nutritional questionnaire in children with chronic kidney disease, obesity, or hypertension. Clin Nephrol. 2021; 96(1): 36-42. doi: 10.5414/CNP96S07

24. Verney J, Metz L, Chaplais E, Cardenoux C, Pereira B, Thivel D. Bioelectrical impedance is an accurate method to assess body composition in obese but not severely obese adolescents. Nutr Res. 2016; 36(7): 663-670. doi: 10.1016/j.nutres.2016.04.003

25. Rusek W, Adamczyk M, Baran J, Leszczak J, Inglot G, Baran R, et al. Is there a link between balance and body mass composition in children and adolescents? Int J Environ Res Public Health. 2021; 18(19): 10449. doi: 10.3390/ijerph181910449

26. Firsova LA, Zavyalova AN, Lebedev DA. Physical development of children with chronic kidney decease. Nutrition. 2020; 10(2): 5-10. (In Russ.). doi: 10.20953/2224-5448-2020-2-5-11

27. Torun Bayram M, Kavukçu S, Soylu A. Body composition with bioelectrical impedance analysis and body growth in latediagnosed vesicoureteral reflux. Minerva Pediatr. 2017; 69(3): 174180. doi: 10.23736/S0026-4946.16.04233-X

28. Ivanov DO, Novikova VP, Zavyalova AN, Shapovalova NS, Yakovleva MN, Savenkova ND, et al. Draft of the Clinical guidelines. Principles of nutritional support in children with chronickidney disease. Aktual’nye problemy abdominal’noy patologii u detey: Materialy XXVIII Kongressa detskikh gastroenterologov Rossii i stran SNG (Moskva, 23–25 marta 2021 g.). Moscow; 2021: 213-288. (In Russ.).

29. Kulakova EN, Nastausheva TL, Kondratjeva IV, Zvyagina TG, Koltakova MP. Transition of adolescents with chronic kidney disease to adult health service: Scoping review. Current Pediatrics. 2021; 20(1): 38-50. (In Russ.). doi: 10.15690/vsp.v20i1.2235